← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 10, 2021Last known activity
Oct 31, 2025
Timeline
2010s
- Jun 1, 2017
Disc Medicine, Inc— Founded
2020s
- Aug 10, 2022
Gemini Therapeutics, Inc.— Acquired
Drugs by trial phase (5 distinct, 12 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 2 via acquisition)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (17)
- NCT07187973Lead sponsorPhase 1Oct 31, 2025
- NCT06985147OfficialPhase 2Aug 12, 2025
- NCT06985147Lead sponsorPhase 2Aug 12, 2025
- NCT06910358OfficialPhase 3Apr 4, 2025
- NCT06910358Lead sponsorPhase 3Apr 4, 2025
- NCT06050915Study directorPhase 1Oct 3, 2023
- NCT06050915Lead sponsorPhase 1Oct 3, 2023
- NCT05883748Lead sponsorPhase 2/Phase 3Sep 30, 2023
- NCT05883748Study directorPhase 2/Phase 3Sep 30, 2023
- NCT05745883Lead sponsorPhase 1Apr 4, 2023
- NCT05745883Study directorPhase 1Apr 4, 2023
- NCT05308472Lead sponsorPhase 2Oct 31, 2022
- NCT05308472Study directorPhase 2Oct 31, 2022
- NCT05320198Lead sponsorPhase 1/Phase 2Jun 6, 2022
- NCT05320198Study directorPhase 1/Phase 2Jun 6, 2022
Details
- Founded
- Cambridge, MA, US Jun 1, 2017
- Last known activity
- Oct 31, 2025